169 related articles for article (PubMed ID: 34619870)
1. [Extraskeletal mesenchymal chondrosarcoma in central nerve system: a clinicopathological analysis].
Wang YJ; Wang LM; Meng YH; Qi CH; Zhao LH; Lu DH; Teng LH
Zhonghua Bing Li Xue Za Zhi; 2021 Oct; 50(10):1157-1162. PubMed ID: 34619870
[No Abstract] [Full Text] [Related]
2. [Mesenchymal chondrosarcoma in central nervous system: a clinicopathological analysis].
Huang Q; Chen YP; Song FL; Zheng LM; Liu XY; Zhang S; Wang XF
Zhonghua Bing Li Xue Za Zhi; 2021 Aug; 50(8):870-875. PubMed ID: 34344069
[No Abstract] [Full Text] [Related]
3. Are meningeal hemangiopericytoma and mesenchymal chondrosarcoma the same?: a study of HEY1-NCOA2 fusion.
Fritchie KJ; Jin L; Ruano A; Oliveira AM; Rubin BP
Am J Clin Pathol; 2013 Nov; 140(5):670-4. PubMed ID: 24124145
[TBL] [Abstract][Full Text] [Related]
4. [Clinicopathology analysis of mesenchymal chondrosarcoma in soft tissue].
Cai L; Gao ZF; Huang XY
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):501-5. PubMed ID: 17068623
[TBL] [Abstract][Full Text] [Related]
5. Extraskeletal Mesenchymal Chondrosarcoma of Central Nervous System - A Rare but Aggressive Tumor: Analysis of Five Cases.
Chatterjee D; Radotra BD; Madan R; Gupta SK
Neurol India; 2022; 70(1):285-288. PubMed ID: 35263897
[TBL] [Abstract][Full Text] [Related]
6. Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases.
Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Rushing EJ
Hum Pathol; 2010 May; 41(5):653-62. PubMed ID: 20138330
[TBL] [Abstract][Full Text] [Related]
7. Minute mesenchymal chondrosarcoma within osteochondroma: an unexpected diagnosis confirmed by HEY1-NCOA2 fusion.
Toki S; Motoi T; Miyake M; Kobayashi E; Kawai A; Yoshida A
Hum Pathol; 2018 Nov; 81():255-260. PubMed ID: 29596896
[TBL] [Abstract][Full Text] [Related]
8. Immunoprofile of mesenchymal chondrosarcoma: aberrant desmin and EMA expression, retention of INI1, and negative estrogen receptor in 22 female-predominant central nervous system and musculoskeletal cases.
Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Santi M; Judkins AR; Rushing EJ
Ann Diagn Pathol; 2010 Feb; 14(1):8-14. PubMed ID: 20123451
[TBL] [Abstract][Full Text] [Related]
9. NKX3.1 a useful marker for mesenchymal chondrosarcoma: An immunohistochemical study.
Syed M; Mushtaq S; Loya A; Hassan U
Ann Diagn Pathol; 2021 Feb; 50():151660. PubMed ID: 33302222
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic involvement by mesenchymal chondrosarcoma harboring the HEY1-NCOA2 gene fusion.
Cohen JN; Solomon DA; Horvai AE; Kakar S
Hum Pathol; 2016 Dec; 58():35-40. PubMed ID: 27544802
[TBL] [Abstract][Full Text] [Related]
11. Primary spinal intradural mesenchymal chondrosarcoma with detection of fusion gene HEY1-NCOA2: A paediatric case report and review of the literature.
Andersson C; Osterlundh G; Enlund F; Kindblom LG; Hansson M
Oncol Lett; 2014 Oct; 8(4):1608-1612. PubMed ID: 25202377
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal chondrosarcoma of the head and neck with HEY1::NCOA2 fusion: A clinicopathologic and molecular study of 13 cases with emphasis on diagnostic pitfalls.
Xu B; Rooper LM; Dermawan JK; Zhang Y; Suurmeijer AJH; Dickson BC; Demicco EG; Antonescu CR
Genes Chromosomes Cancer; 2022 Nov; 61(11):670-677. PubMed ID: 35672279
[TBL] [Abstract][Full Text] [Related]
13. HEY1-NCOA2 expression modulates chondrogenic differentiation and induces mesenchymal chondrosarcoma in mice.
Tanaka M; Homme M; Teramura Y; Kumegawa K; Yamazaki Y; Yamashita K; Osato M; Maruyama R; Nakamura T
JCI Insight; 2023 May; 8(10):. PubMed ID: 37212282
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic pitfall in the diagnosis of mesenchymal chondrosarcoma arising in the central nervous system.
Lin L; Varikatt W; Dexter M; Ng T
Neuropathology; 2012 Feb; 32(1):82-90. PubMed ID: 21615516
[TBL] [Abstract][Full Text] [Related]
15. NKX3.1 immunohistochemistry and methylome profiling in mesenchymal chondrosarcoma: additional diagnostic value for a well-defined disease?
Glauser S; Ameline B; Andrei V; Harder D; Pauli C; Trautmann M; Hartmann W; Baumhoer D
Pathology; 2023 Aug; 55(5):621-628. PubMed ID: 37225644
[TBL] [Abstract][Full Text] [Related]
16. Genomic profiling identifies genes and pathways dysregulated by HEY1-NCOA2 fusion and shines a light on mesenchymal chondrosarcoma tumorigenesis.
Qi W; Rosikiewicz W; Yin Z; Xu B; Jiang H; Wan S; Fan Y; Wu G; Wang L
J Pathol; 2022 Aug; 257(5):579-592. PubMed ID: 35342947
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathologic and immunohistochemical study of 23 cases of mesenchymal chondrosarcoma].
Pang ZG; He XZ; Wu LY; Wei W; Liu XY; Liao DY; Li FY; Zhang XL
Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):368-72. PubMed ID: 21914343
[TBL] [Abstract][Full Text] [Related]
18. OLIG2 Immunolabeling of Mesenchymal Chondrosarcoma: Report of 14 Cases.
Yao K; Duan Z; Yang S; Du Z; Wang Y; Qi X
J Neuropathol Exp Neurol; 2020 Sep; 79(9):959-965. PubMed ID: 32770197
[TBL] [Abstract][Full Text] [Related]
19. Novel low-grade renal spindle cell neoplasm with HEY1::NCOA2 fusion that is distinct from mesenchymal chondrosarcoma.
Miller TI; Mantilla JG; Wang W; Liu YJ; Tretiakova M
Genes Chromosomes Cancer; 2023 Mar; 62(3):171-175. PubMed ID: 36416671
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal chondrosarcoma diagnosed on FISH for HEY1-NCOA2 fusion gene.
Moriya K; Katayama S; Onuma M; Rikiishi T; Hosaka M; Watanabe M; Hasegawa T; Sasahara Y; Kure S
Pediatr Int; 2014 Oct; 56(5):e55-7. PubMed ID: 25336010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
